Use of Wallstent device as an embolic protection device during stenting of aortic thrombus.

Autor:	Mak MHW; Vascular Surgery Service, Department of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore., Tan GWL; Vascular Surgery Service, Department of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore., Wu YW; Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore, Singapore., Quek LHH; Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore, Singapore.
Jazyk:	angličtina
Zdroj:	Journal of vascular surgery cases and innovative techniques [J Vasc Surg Cases Innov Tech] 2023 Oct 03; Vol. 9 (4), pp. 101340. Date of Electronic Publication: 2023 Oct 03 (Print Publication: 2023).
DOI:	10.1016/j.jvscit.2023.101340
Abstrakt:	Blue toe syndrome can occur due to distal embolization from proximal lesions such as an aortic thrombus. We describe the case of a patient who presented with chronic limb threatening ischemia due to a flow-limiting infrarenal aortic thrombus, with gangrene from distal embolization to the left fifth toe, and was successfully treated with endovascular aortic stent graft insertion. Distal embolization during instrumentation was successfully prevented by using a partially deployed Wallstent (Boston Scientific) as an embolic protection device. The reconstrainable Wallstent device can be considered for distal thromboembolic protection during aortic stenting, in particular, when distal embolization is a concern and commercial devices are not readily available. Competing Interests: None. (© 2023 The Author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu